These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11321356)

  • 1. Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment.
    Montalto G; Giannitrapani L; Soresi M; Virruso L; Martino DD; Gambino R; Carroccio A; Cervello M
    Inflammation; 2001 Apr; 25(2):101-8. PubMed ID: 11321356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment.
    Montalto G; Giannitrapani L; Soresi M; Florena A; Di Martino D; Franco V; Carroccio A; Cervello M
    Intervirology; 2003; 46(1):35-42. PubMed ID: 12566697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Cervello M; Virruso L; Lipani G; Giannitrapani L; Soresi M; Carroccio A; Gambino R; Sanfililippo R; Marasà L; Montalto G
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):345-51. PubMed ID: 10870645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon.
    Scotto G; Grimaldi M
    Dig Dis Sci; 1998 Oct; 43(10):2173-6. PubMed ID: 9790450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    J Gastroenterol; 2000; 35(2):105-11. PubMed ID: 10680665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH; Kim YM; Kim SG
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon.
    Freni MA; Ajello A; Spadaro A; Fava A; Calapristi I; Marafioti T; Alessi N; Resta ML; Ferraù O
    Hepatogastroenterology; 1997; 44(17):1295-301. PubMed ID: 9356842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis C.
    Di Cesare E; Spadaro A; Ajello A; Ferraù O; Alessi N; Luigiano C; Melluso R; Freni MA
    Clin Chem Lab Med; 2005; 43(8):823-6. PubMed ID: 16201891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.
    Di Fazio I; Motta M; Musumeci S; Neri S; Pistone G; Malaguarnera M
    J Interferon Cytokine Res; 2004 Oct; 24(10):594-9. PubMed ID: 15626156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis.
    Simpson KJ; Jones AL; Forbes Howie A; Hayes PC
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):455-60. PubMed ID: 7542148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-year interferon-alpha 2a treatment in patients with chronic hepatitis C and persistently normal transaminase activity.
    Tran A; Longo F; Ouzan D; Bianchi D; Pradier C; Saint-Paul MC; Sattonnet C; Laffont C; Dantin S; Piche T; Benzaken S; Rampal P
    Scand J Gastroenterol; 2000 Apr; 35(4):433-7. PubMed ID: 10831269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
    Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
    Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.
    Brinovec V; Lesnicar G; Maticic M; Meglic-Volkar J; Poljak M; Seme K; Ferlan-Marolt V
    Hepatogastroenterology; 2002; 49(47):1320-5. PubMed ID: 12239935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
    J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels.
    Kronenberger B; Rüster B; Lee JH; Sarrazin C; Roth WK; Herrmann G; Zeuzem S
    J Hepatol; 2000 Oct; 33(4):640-7. PubMed ID: 11059870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.
    Abdel-Rahman M; Saad Y; El-Raziky M; Zayed N; El-Akel W; Said M; El-Beshlawy M; Esmat G
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):479-84. PubMed ID: 23540379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
    Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
    Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.
    Caroleo B; Gallelli L; Staltari O; De Sarro G; Guadagnino V
    Intervirology; 2008; 51(6):407-9. PubMed ID: 19258719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.